Building an investment-ready market case for a CRT optimization device
Quantified the US and European market opportunity for a novel CRT (cardiac resynchronization therapy) optimization system and translated physician feedback into a credible commercial and exit narrative for fundraising.
- Market Sizing / Market Potential (TAM/SAM/SOM)
- Global KOL Identification & Profiling
- M&A Due Diligence
The brief
Quantify the US and European opportunity for a novel CRT optimization system
- Validate current CRT treatment pathways
- Establish what drives — and what blocks — adoption
- Size the US and European opportunity bottom-up
- Translate the findings into an investor-ready narrative
The client was heading into its next fundraising round with no physician or KOL feedback in hand.
The problem
A highly specialized, competitive segment where the available market data was fragmented and often unreliable
- No physician or KOL feedback to build a story on
- Published CRM market data inconsistent
- Top-down sizing would not survive investor scrutiny
- Commercial positioning still undefined
Cardiac rhythm management leaves very little room for approximate numbers.
Our approach
In-depth interviews across three stakeholder groups, feeding a bottom-up market model
- Electrophysiologists, cardiac surgeons and hospital decision-makers
- Interviews run across both the US and Europe
- Model built on epidemiology data and procedure incidence
- Referral patterns and hospital-penetration assumptions layered in
Every revenue figure traces back to an assumption a physician actually validated.
Key outcomes
An investment-ready commercial case, with a revenue trajectory tied to physician-validated adoption assumptions
- US and Europe market opportunity assessment
- Revenue model tied to market-penetration assumptions
- Market-entry priorities and commercial positioning
- Exit-value framework for investor conversations
Feedback converged on where the technology has to prove itself clinically first.
Related services
Facing a similar challenge?
Tell us what decision you're facing. We'll turn it into a clear, evidence-backed answer.